sulforaphane has been researched along with Angiogenesis, Pathologic in 10 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Angiogenesis plays an important role in hepatocellular carcinoma (HCC), the inhibition of which is explored for cancer prevention and treatment." | 5.46 | Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling. ( Akbareian, SE; Atkinson, SJ; Bao, Y; Liu, P; Munsterberg, A; Robinson, SD; Zhou, Z, 2017) |
| "Angiogenesis plays an important role in hepatocellular carcinoma (HCC), the inhibition of which is explored for cancer prevention and treatment." | 1.46 | Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling. ( Akbareian, SE; Atkinson, SJ; Bao, Y; Liu, P; Munsterberg, A; Robinson, SD; Zhou, Z, 2017) |
| "Sorafenib (SO) is a promising new multikinase inhibitor for treatment of advanced kidney and liver cancers." | 1.36 | Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics. ( Baumann, B; Büchler, MW; Gladkich, J; Herr, I; Kallifatidis, G; Liu, L; Mattern, J; Rausch, V; Salnikov, AV; Schemmer, P; Wirth, T; Zöller, M, 2010) |
| "Markers of apoptosis, angiogenesis, and metastasis were measured by immunohistochemistry." | 1.35 | Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis. ( Ganapathy, S; Shankar, S; Srivastava, RK, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, P | 1 |
| Atkinson, SJ | 1 |
| Akbareian, SE | 1 |
| Zhou, Z | 1 |
| Munsterberg, A | 1 |
| Robinson, SD | 1 |
| Bao, Y | 1 |
| Zhang, YK | 1 |
| Wang, H | 1 |
| Guo, YW | 1 |
| Yue, Y | 1 |
| Shankar, S | 3 |
| Ganapathy, S | 1 |
| Srivastava, RK | 2 |
| Davis, R | 1 |
| Singh, KP | 1 |
| Kurzrock, R | 1 |
| Rausch, V | 1 |
| Liu, L | 1 |
| Kallifatidis, G | 1 |
| Baumann, B | 1 |
| Mattern, J | 1 |
| Gladkich, J | 1 |
| Wirth, T | 1 |
| Schemmer, P | 1 |
| Büchler, MW | 1 |
| Zöller, M | 1 |
| Salnikov, AV | 1 |
| Herr, I | 1 |
| Li, SH | 1 |
| Fu, J | 1 |
| Watkins, DN | 1 |
| Bertl, E | 1 |
| Bartsch, H | 1 |
| Gerhäuser, C | 1 |
| Jackson, SJ | 1 |
| Singletary, KW | 1 |
| Venema, RC | 1 |
| Juge, N | 1 |
| Mithen, RF | 1 |
| Traka, M | 1 |
| Annabi, B | 1 |
| Rojas-Sutterlin, S | 1 |
| Laroche, M | 1 |
| Lachambre, MP | 1 |
| Moumdjian, R | 1 |
| Béliveau, R | 1 |
1 review available for sulforaphane and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Molecular basis for chemoprevention by sulforaphane: a comprehensive review.
Topics: Anticarcinogenic Agents; Apoptosis; Diet; DNA Adducts; Enzymes; Humans; Isothiocyanates; Models, Bio | 2007 |
9 other studies available for sulforaphane and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling.
Topics: Animals; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Cell Survival; Chick Embryo; | 2017 |
Novel role of Snail 1 in promoting tumor neoangiogenesis.
Topics: Anticarcinogenic Agents; Antigens, CD34; Cell Transformation, Neoplastic; Endoglin; Endothelial Cell | 2019 |
Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis.
Topics: Animals; Apoptosis; Cell Proliferation; Disease Models, Animal; Drug Synergism; Isothiocyanates; Mal | 2008 |
Sulforaphane inhibits angiogenesis through activation of FOXO transcription factors.
Topics: Angiogenesis Inhibitors; Anticarcinogenic Agents; Cell Line; Cell Movement; Endothelium, Vascular; E | 2009 |
Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Animals; Antineoplastic Combined Chemothera | 2010 |
Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; | 2013 |
Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention.
Topics: Angiogenesis Inhibitors; Anticarcinogenic Agents; Basement Membrane; Cell Line; Cell Proliferation; | 2006 |
Sulforaphane suppresses angiogenesis and disrupts endothelial mitotic progression and microtubule polymerization.
Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Cattle; Cell Proliferation; Cells, Cultur | 2007 |
The diet-derived sulforaphane inhibits matrix metalloproteinase-9-activated human brain microvascular endothelial cell migration and tubulogenesis.
Topics: Anticarcinogenic Agents; Blood-Brain Barrier; Brain; Brain Neoplasms; Brassica; Capillaries; Cell Li | 2008 |